| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JC.85.1.219 |
| P698 | PubMed publication ID | 10634390 |
| P50 | author | Elizabeth Barrett-Connor | Q37322423 |
| P2093 | author name string | Laughlin GA | |
| Sartoris DJ | |||
| Schneider DL | |||
| Mueller JE | |||
| von Mühlen DG | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone fracture | Q68833 |
| P304 | page(s) | 219-223 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study | |
| P478 | volume | 85 |
| Q44752083 | Age-related changes in sex steroid levels influence bone mineral density in healthy Indian men. |
| Q35784175 | Age-related changes in testosterone and the role of replacement therapy in older men. |
| Q55512155 | Analysis of correlation between estradiol and fracture of femur neck. |
| Q35567346 | Androgen therapy in the aging male |
| Q79811504 | Androgens and bone |
| Q34511442 | Andropause: clinical implications of the decline in serum testosterone levels with aging in men. |
| Q35101538 | Aromatase activity and bone loss in men. |
| Q45097773 | Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study. |
| Q46068049 | Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study |
| Q37176133 | Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? |
| Q79361090 | Bilateral osteonecrosis of the femoral head in an adult man affected by congenital estrogen deficiency |
| Q35063675 | Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer |
| Q45884165 | Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels |
| Q34229298 | Clinical implications and management of oestrogen deficiency in the male. |
| Q28216806 | Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men |
| Q44297420 | Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer |
| Q35624509 | Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism |
| Q46459550 | Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. |
| Q35431110 | Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid |
| Q55344691 | Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial. |
| Q36910469 | Emerging therapies to prevent skeletal morbidity in men with prostate cancer |
| Q46925977 | Endogenous hormones, muscle strength, and risk of fall-related fractures in older women |
| Q36716938 | Estrogen hydroxylation in osteoporosis |
| Q35229925 | Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women. |
| Q37520591 | Estrogens as regulators of bone health in men. |
| Q30090708 | Estrogens in Male Physiology |
| Q36892956 | Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer |
| Q37563995 | Fracture prevention in men. |
| Q42618966 | Genome-wide association study of sex hormones, gonadotropins and sex hormone-binding protein in Chinese men. |
| Q36799755 | High Serum SHBG Predicts Incident Vertebral Fractures in Elderly Men |
| Q36568540 | Male osteoporosis: A review |
| Q36203210 | Male osteoporosis: epidemiology and pathophysiology |
| Q36906736 | Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club |
| Q44466090 | Management of treatment-related osteoporosis in men with prostate cancer |
| Q34135491 | Measuring fecal testosterone in females and fecal estrogens in males: comparison of RIA and LC/MS/MS methods for wild baboons (Papio cynocephalus) |
| Q44961176 | Men with osteoporosis: are they being treated fairly? |
| Q35121399 | Men, bone and estrogen: unresolved issues. |
| Q36207061 | Oestradiol levels and superoxide dismutase activity in age-related cataract: a case-control study. |
| Q78306109 | Osteoporosis |
| Q34856701 | Osteoporosis during androgen deprivation therapy for prostate cancer |
| Q57244901 | Osteoporosis in Men |
| Q34993317 | Osteoporosis in elderly: prevention and treatment |
| Q56110001 | Osteoporosis in men |
| Q35680543 | Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment |
| Q38517233 | Prediction of incident osteoporotic fractures in elderly women using the free estradiol index |
| Q46612560 | Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men's Osteoporosis Study |
| Q37189981 | Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength |
| Q36403582 | Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. |
| Q44734291 | Relationships between hormonal status and cataract in french postmenopausal women: the POLA study |
| Q34280148 | Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency. |
| Q44965046 | Role of sex steroids in the regulation of bone morphology in men. The MINOS study. |
| Q45051508 | SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer |
| Q35036493 | Sex and gender considerations in male patients with osteoporosis |
| Q35188685 | Sex hormones and male health: effects on components of the frailty syndrome |
| Q36586017 | Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. |
| Q37130045 | Sex hormones, their receptors and bone health |
| Q34437537 | Sex steroid actions in male bone |
| Q24594450 | Testosterone and the male skeleton: a dual mode of action |
| Q37665507 | The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density |
| Q36328511 | The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. |
| Q37341852 | The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. |
| Q27026164 | The endocrine role of estrogens on human male skeleton |
| Q35109134 | The importance of oestrogens in males. |
| Q37017423 | The osteoporotic male: overlooked and undermanaged? |
| Q38074897 | The pathogenesis, treatment and prevention of osteoporosis in men. |
| Q37145381 | The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative |
| Q34435641 | Unresolved issues in osteoporosis in men. |
| Q36045845 | Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis |
| Q73940559 | [Estrogens still and always?] |
Search more.